Scott Phillips Email & Phone Number

New Haven, Connecticut, Us

Founding executive for small molecule discovery stage company during seed stage and venture funding; successfully raised $200 million of equity financing with top tier venture capital firms. Led collaboration and business partnership term sheet discussions with large pharmaceutical companies. Negotiated multi-million $ venture debt facility on favorable terms with top commercial bank. Leader of G&A functions, including financing, HR, IT, procurement; member of IP strategy team. Drove successful negotiations of contracts and partnerships, providing risk mitigation and saving the company over $1.5 million of operating expenses during initial 3-year period. Led implementation of key financial software and controls related to financial audit, ERP, expense reporting, equity reporting, lab procurement, HR/payroll. Built multi-year, multi-dimensional financial reporting and forecasting process and financial reporting to Board.

Fractional CFO and founding executive for IO antibody company during seed stage through Series A financing, successfully raising $65 million Series A financing with top tier venture capital firms. Leader of all G&A functions, including financing, HR, IT, procurement; member of IP strategy team. Negotiated key agreements including manufacturing, CMC, non-clinical agreements, as well as broad antibody development agreement to develop next generation antibodies. Led implementation of key financial software and controls related to ERP, expense reporting, equity reporting, lab procurement, HR/payroll. Built multi-year, multi-dimensional financial reporting and forecasting process and financial reporting to Board.

Acting Chief Financial Officer - Amylyx Pharmaceuticals Acting Chief Financial Officer - Bioasis Technologies Acting Chief Accounting Officer - Allovir Consulting CFO practice with clients in CT and MA, with focus on supporting early stage public and private organizations in financial strategy and operations, commercial strategy, accounting and cost controls. Involvement in capital raise preparation, S-1 readiness, financial decision-making, complex accounting matters, process improvement, forecasting and financial start-up activities.

New Haven, Ct, Us

Created accounting and finance processes for new public company, including financial planning and analysis, accounting and SEC reporting. Established deliverables for Audit Committee, management reporting, monthly closing and earnings releases. Developed plan to remediate multiple material weaknesses and achieve Sarbanes-Oxley 404 compliance. Successfully led efforts to complete first companywide budget, overhauled closing process, implemented new ERP system and filed Company’s initial Annual Report on 10K.

Boston, Massachusetts, Us

Established Business Finance group comprised of strategic finance, enterprise-wide financial planning and analysis and global finance business partnership functions, leading ~80 professionals in 25+ countries. Drove decision making for forecasting, guidance setting and long-term financial planning, while managing critical deliverables for Board reporting and earnings call preparation. Led cross- functional teams in integrated financial close and special projects including acquisition integration and restructuring. Member of Alexion Operating Committee and Finance Leadership team.

Boston, Massachusetts, Us

Established global controllership and financial services functions, including accounting, shared services, procurement and manufacturing finance disciplines, leading ~100 professionals. Served as Principal Accounting Officer certifying corporate SEC filings from 2007 through 2014, managing critical accounting and reporting matters and Audit and Finance Committee reporting. Led cross- finance teams in multiple accounting, finance and shared service locations (Cheshire HQ, Lausanne Switzerland, Dublin Ireland, Miami, Mumbai India and other country locations).

Gb

Executed diverse projects, including audit engagements, SEC filings, financial due diligence and other special projects in the technology industry group for public and private clients. Leveraged expertise in understanding, applying and articulating complex technical issues impacting technology companies, with focus on revenue recognition, purchase business combinations and equity instruments. Advised public companies in SEC reporting matters, including 1934 Act periodic filings (10-K, 10-Q, 8-K), 1933 Act filings (S-1, S-3), SEC comment letters and comfort letters.

London, Gb

Bsba, Mac, Accounting

Education record